← Leaderboards
Monique Evangeline Hinchcliff
Northwestern University At Chicago
$3,488,191
Attributed
$3,688,331
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $703K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,688,331 · 4
By mechanism
R01$2,898,159 · 2
R21$400,280 · 1
K23$389,892 · 1
Top collaborators
- Michael L Whitfield2 shared
Most similar at Northwestern University At Chicago
Same institution · by research overlap
- Cara J Gottardi$10,515,510
- Alexander Misharin$14,331,947
- Renea Poppino Jablonski$100,059
- Gabrielle Liu$116,648
- Mary Clare Masters$643,496
Others in their field
Top investigators on “Systemic Scleroderma”
- Eugene W. St Clair · Duke University$24,182,181
- John Varga · University Of Illinois At Chicago$13,781,985
- Carol A Feghali-Bostwick · University Of Pittsburgh At Pittsburgh$11,771,501
- Judith A James · Oklahoma Medical Research Foundation$11,331,322
- Robert M Elashoff · John Wayne Cancer Institute$10,394,671
- Maria Trojanowska · Boston University Medical Campus$10,085,547
Research focus
Systemic SclerodermaSkinSclerodermaProgramsPhenotypePathway InteractionsUniversitiesComplexGene ExpressionCellsGenesGene Expression ProfileMolecularSkin DisorderBiopsyFibrosisRheumatologyEnvironmentBioinformaticsMultidisciplinaryPlayLungResourcesGenetic
Grant awards (10)
Validating Novel Outcomes to Enable Systemic Sclerosis Calcinosis Cutis Clinical Trials$249,218
R01 · FY2025 · AR · contact PI
Pathogenic Wnt-beta catenin target genes in macrophages and fibrosis$634,106
R01 · FY2023 · AR · contact PI
Pathogenic Wnt-beta catenin target genes in macrophages and fibrosis$651,098
R01 · FY2022 · AR · contact PI
Pathogenic Wnt-beta catenin target genes in macrophages and fibrosis$660,761
R01 · FY2020 · AR · contact PI
Pathogenic Wnt-beta catenin target genes in macrophages and fibrosis$702,976
R01 · FY2019 · AR · contact PI
Molecular Biomarkers of Improvement for Patients with Systemic Sclerosis in an Open Label Trial of Mycophenolate Mofetil$174,900
R21 · FY2016 · AR
Molecular biomarkers of improvement for patients with systemic sclerosis in an open label trial of mycophenolate mofetil$225,380
R21 · FY2015 · AR
Predictive Ability of Gene Expression Signatures In Skin as SSc Biomarkers$129,964
K23 · FY2015 · AR · contact PI
Predictive Ability of Gene Expression Signatures In Skin as SSc Biomarkers$129,964
K23 · FY2014 · AR · contact PI
Predictive Ability of Gene Expression Signatures In Skin as SSc Biomarkers$129,964
K23 · FY2013 · AR · contact PI